From January 2010 through February 2012, LCGO allegedly purchased a portion of the drugs used by Dr. Eltabbakh in chemotherapy treatments from a Canadian drug distributor and other sources. The drugs had not received final marketing approval from the FDA and were not covered by Medicare and Medicaid.
Regarding the settlement, Phillip M. Coyne, special agent in charge of HHS’ Office of Inspector General, said, “We will continue to ensure that Medicare and Medicaid only pay for drugs that meet the coverage requirement of the programs.”
More articles on healthcare fraud:
Fraud, theft and a teen’s fixation with playing physician
Owner of billing company pleads guilty in $2M Medicare fraud scheme
Healthcare CEO faces life in prison for fraud that led to 2 patient deaths
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
